CoChat

NIA‐AA Alzheimer's Disease Framework: Clinical Characterization of Stages

Open access
Petersen, Ronald C., Wiste, Heather J., Weigand, Stephen D., Fields, Julie A., Geda, Yonas E., Graff‐Radford, Jonathan, Knopman, David S., Kremers, Walter K., Lowe, Val, Machulda, Mary M., Mielke, Michelle M., Stricker, Nikki H., Therneau, Terry M., Vemuri, Prashanthi, Jack, Clifford R. · 2021 · Annals of Neurology
Cited by 70

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Background: To operationalize the National Institute on Aging – Alzheimer's Association (NIA‐AA) Research Framework for Alzheimer's Disease 6‐stage continuum of clinical progression for persons with abnormal amyloid. Methods: The Mayo Clinic Study of Aging is a population‐based longitudinal study of aging and cognitive impairment in Olmsted County, Minnesota. We evaluated persons without dementia having 3 consecutive clinical visits. Measures for cross‐sectional categories included objective cognitive impairment (OBJ) and function (FXN). Measures for change included subjective cognitive impairment (SCD), objective cognitive change (ΔOBJ), and new onset of neurobehavioral symptoms (ΔNBS). We calculated frequencies of the stages using different cutoff points and assessed stability of the stages over 15 months. Results: Among 243 abnormal amyloid participants, the frequencies of the stages varied with age: 66 to 90% were classified as stage 1 at age 50 but at age 80, 24 to 36% were stage 1, 32 to 47% were stage 2, 18 to 27% were stage 3, 1 to 3% were stage 4 to 6, and 3 to 9% were indeterminate. Most stage 2 participants were classified as stage 2 because of abnormal ΔOBJ only (44–59%), whereas 11 to 21% had SCD only, and 9 to 13% had ΔNBS only. Short‐term stability varied by stage and OBJ cutoff points but the most notable changes were seen in stage 2 with 38 to 63% remaining stable, 4 to 13% worsening, and 24 to 41% improving (moving to stage 1). Interpretation: The frequency of the stages varied by age and the precise membership fluctuated by the parameters used to define the stages. The staging framework may require revisions before it can be adopted for clinical trials. ANN NEUROL 2021;89:1145–1156

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.26071

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 70

Metadata

Authors
Petersen, R. C., Wiste, H. J., Weigand, S. D., Fields, J. A., Geda, Y. E., Graff‐Radford, J., Knopman, D. S., Kremers, W. K., Lowe, V., Machulda, M. M., Mielke, M. M., Stricker, N. H., Therneau, T. M., Vemuri, P., & Jack, C. R.
Venue
Annals of Neurology
Publisher
Wiley
Published
2021-04-06
Volume
89
Issue
6
Pages
1145-1156
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W3143220268
Cited by
70
References
8
FWCI
6.82
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: NIA‐AA Alzheimer's Disease Framework: Clinical Characterization of Stages. https://app.cochat.ai/papers/10.1002/ana.26071
The paper
Petersen, R. C., Wiste, H. J., Weigand, S. D., Fields, J. A., Geda, Y. E., Graff‐Radford, J., Knopman, D. S., Kremers, W. K., Lowe, V., Machulda, M. M., Mielke, M. M., Stricker, N. H., Therneau, T. M., Vemuri, P., & Jack, C. R. (2021). NIA‐AA Alzheimer's Disease Framework: Clinical Characterization of Stages. Annals of Neurology. https://doi.org/10.1002/ana.26071

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.